Legal Representation
Attorney
Nancy Sabarra
USPTO Deadlines
Next Deadline
64 days remaining
NOA E-Mailed - SOU Required
Due Date
February 27, 2026
Extension Available
Until August 27, 2026
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 26, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 26, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 25, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 25, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 26, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 26, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 27, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 13, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 24, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 22, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 21, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 21, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 18, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 18, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| May 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 22, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 15, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 21, 2023 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Feb 21, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 15, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Nov 30, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 11, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting awareness of influenza immunization and vaccination programs; providing business consulting and consumer information services related to pharmaceuticals and vaccines; providing a website for practice management and administrative support services to healthcare providers, medical professionals, and pharmacies; providing online information for healthcare providers, medical professionals, and pharmacies about practice management and administrative support related to pharmaceuticals and vaccines; business management consultation in the field of leadership development
Class 041
Educational services in the nature of seminars in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; leadership training programs in the fields of medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; arranging and conducting conferences and meetings in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza
Class 042
Pharmaceutical research and development; medical research services; providing medical and scientific research in the fields of pharmaceuticals, vaccines, and influenza; providing information in the fields of pharmaceutical and vaccine research and development and influenza research; providing a website featuring information in the fields of pharmaceutical and vaccine research and influenza research; consulting services related to research and development of medicines, pharmaceuticals, and vaccines; technical consulting in the field of pharmaceutical studies
Class 044
Medical services; health care services; medical information services; providing a website with medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; providing medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; pharmaceutical consultation; consulting services relating to the prophylactic and therapeutic properties of vaccines
Additional Information
Design Mark
The mark consists of the words "PEDIATRIC INFLUENZA" above the words "LEADERSHIP FORUM". Above the word "INFLUENZA" is a crescent-shaped design composed of dots of varying sizes. The word "PEDIATRIC" and the letters "IN" and "ENZA" in the word "INFLUENZA" appear in blue. The words "LEADERSHIP FORUM" and the letters "FLU" in the word "INFLUENZA" appear in green. The dots on the left side of the crescent-shaped design appear in blue, and the dots on the right side of the crescent-shaped design appear in green. The color white represents transparent area and is not part of the mark.
Color Claim
The color(s) blue and green is/are claimed as a feature of the mark.
Classification
International Classes
035
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PEDIATRIC INFLUENZA LEADERSHIP FORUM"